| A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia (NCT00922389) | Beike Biotech India Pvt.ltd | 2009-07-01 |
| Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer (NCT00888108) | Abbott | 2009-07-01 |
| Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors. (NCT00849550) | Herbert Hurwitz | 2009-07-01 |
| Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer (NCT00907179) | University of Pittsburgh | 2009-07-01 |
| Lopinavir (LPV) Dose Reduction (NCT01159275) | The HIV Netherlands Australia Thailand Research Collaboration | 2009-07-01 |
| Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer (NCT05278728) | Biotech Pharmaceutical Co., Ltd. | 2009-07-01 |
| Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC) (NCT00971126) | National Health Research Institutes, Taiwan | 2009-07-01 |
| A Study to Investigate the Food Effect on the Pharmacokinetics of YM178 in Healthy, Non-elderly Volunteers (NCT00965926) | Astellas Pharma Inc | 2009-07-01 |
| Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors (NCT00942682) | Dana-Farber Cancer Institute | 2009-07-01 |
| Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders (NCT01224496) | Singapore General Hospital | 2009-07-01 |
| Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subjects (NCT00947687) | Pulmatrix Inc. | 2009-07-01 |
| ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors (NCT00946335) | National Cancer Institute (NCI) | 2009-07-01 |
| Stereotactic Radiation Therapy in Treating Patients With Liver Metastases (NCT00938457) | Mayo Clinic | 2009-07-01 |
| A Bioequivalence Study Of AG-013736 Tablets In Healthy Volunteers (NCT00905814) | Pfizer | 2009-07-01 |
| Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) (NCT00968240) | Northwell Health | 2009-07-01 |
| Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation (NCT00947440) | Abbott | 2009-07-01 |
| Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults (NCT00943358) | University Hospitals, Leicester | 2009-07-01 |
| AZD7325 Japan Multiple Ascending Dose (MAD) Study (NCT00945425) | AstraZeneca | 2009-07-01 |
| A Study to Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Presence of Docetaxel in Patients With HER2-Positive Metastatic or Locally Advanced Inoperable Cancer (NCT00927589) | Genentech, Inc. | 2009-07-01 |
| Dose Proportionality of Different Dose Strengths of Linagliptin Tablets After Oral Administration to Healthy Male and Female Volunteers (NCT02183480) | Boehringer Ingelheim | 2009-07-01 |
| Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects (NCT00908271) | AstraZeneca | 2009-07-01 |
| A Repeat Dose Positron Emission Tomography Study With GSK1144814 (NCT01209039) | GlaxoSmithKline | 2009-07-01 |
| Single-blind Evaluation of Device to Nail Micro-drilling in Onychomycosis (NCT00941317) | Galderma R&D | 2009-07-01 |
| Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma (NCT00884546) | Bristol-Myers Squibb | 2009-07-01 |
| The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers (NCT01022333) | Women's College Hospital | 2009-07-01 |
| Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer (NCT00946881) | Steba Biotech S.A. | 2009-07-01 |
| Ex Vivo Human Thrombosis Chamber Study (NCT00935506) | Bristol-Myers Squibb | 2009-07-01 |
| Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male Volunteers (NCT02182401) | Boehringer Ingelheim | 2009-07-01 |
| Pharmacokinetics of Single and Multiple Oral Doses of BI 1356 in Healthy Chinese Volunteers (NCT02183532) | Boehringer Ingelheim | 2009-07-01 |
| RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer (NCT00935961) | Memorial Sloan Kettering Cancer Center | 2009-07-01 |
| Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer (NCT00788333) | Bristol-Myers Squibb | 2009-07-01 |
| A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1 (NCT00790673) | Can-Fite BioPharma | 2009-07-01 |
| Study to Investigate the Effects of Melatonin, Temazepam & Zolpidem on Sleep EEG in Men and Women (NCT00940550) | University of Surrey | 2009-07-01 |
| Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine (NCT00937664) | AstraZeneca | 2009-07-01 |
| Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM) (NCT00960791) | AstraZeneca | 2009-07-01 |
| Norspan Transdermal Patches Study in Osteoarthritis Patients (NCT01643759) | Mundipharma (China) Pharmaceutical Co. Ltd | 2009-07-01 |
| CAEB071 Thorough QTc Study in Healthy Volunteers (NCT01594255) | Novartis Pharmaceuticals | 2009-07-01 |
| Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers. (NCT03643575) | Reckitt Benckiser Inc. | 2009-06-30 |
| A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults (NCT00798265) | National Cancer Institute (NCI) | 2009-06-29 |
| Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer (NCT04298333) | Meabco A/S | 2009-06-27 |
| Safety and Tolerability of the Derma Vax(Trademark) Clinical Intradermal Electroporation System in Healthy Subjects (NCT01324843) | National Institute on Aging (NIA) | 2009-06-25 |
| Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) (NCT00831766) | H. Lee Moffitt Cancer Center and Research Institute | 2009-06-25 |
| A Trial In Patients With Advanced Cancer And Leukemia (NCT00878189) | Pfizer | 2009-06-25 |
| A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunteers (NCT00919867) | Shire | 2009-06-24 |
| Kisspeptin Administration in the Adult (NCT00914823) | Massachusetts General Hospital | 2009-06-23 |
| A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol (NCT03274817) | NYU Langone Health | 2009-06-18 |
| Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016) (NCT00925015) | Merck Sharp & Dohme LLC | 2009-06-17 |
| Phase 1/2 Safety and Efficacy Study of AAV-RPE65 Vector to Treat Leber Congenital Amaurosis (NCT00749957) | Beacon Therapeutics | 2009-06-17 |
| A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795 (NCT00920257) | GlaxoSmithKline | 2009-06-16 |
| [11C]Carfentanil PET Study of GSK1521498 (NCT00976066) | GlaxoSmithKline | 2009-06-15 |
| Preventing Motor Vehicle Crashes Among Young Drivers: Evaluation of the Checkpoints Program Presented by the American Automobile Association (NCT00920049) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2009-06-05 |
| Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses (NCT00909688) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-06-05 |
| Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of Macrolides (NCT01026064) | GlaxoSmithKline | 2009-06-04 |
| A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis (NCT00925574) | Centocor, Inc. | 2009-06-04 |
| Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers (NCT03644108) | Reckitt Benckiser Inc. | 2009-06-04 |
| A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors (NCT00880321) | GlaxoSmithKline | 2009-06-04 |
| Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma (NCT00878995) | The University of Texas Medical Branch, Galveston | 2009-06-03 |
| A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male Participants (NCT06143904) | Sanofi | 2009-06-03 |
| A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML) (NCT00875693) | Weill Medical College of Cornell University | 2009-06-02 |
| Sensitivity to Intravenous Nicotine: Genetic Moderators (NCT00969137) | Yale University | 2009-06-02 |
| Convection-Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Parkinson s Disease (NCT00921128) | National Institute of Neurological Disorders and Stroke (NINDS) | 2009-06-02 |
| Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors (NCT00920595) | Cephalon | 2009-06-01 |
| Effect of Light Meal on Pharmacokinetic and Pharmacodynamics of Aliskiren in Patients With Mild to Moderate Hypertension (NCT00933920) | Novartis Pharmaceuticals | 2009-06-01 |
| New Individualized Therapy Trial for Metastatic Colorectal Cancer (NCT00867334) | Inova Health Care Services | 2009-06-01 |
| Efficacy of a Naturally-derived Mouthrinse for Gingival Inflammation (NCT00885599) | Shaare Zedek Medical Center | 2009-06-01 |
| Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease. (NCT01372969) | Tigenix S.A.U. | 2009-06-01 |
| The Effect of Low Level Ozone Exposure on Healthy Volunteers (NCT00468221) | University of North Carolina, Chapel Hill | 2009-06-01 |
| Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating Pegfilgrastim Hospira Compared to Neulasta (Amgen) in Healthy Volunteers (NCT00938678) | Hospira, now a wholly owned subsidiary of Pfizer | 2009-06-01 |
| Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes (NCT00923234) | Technische Universität Dresden | 2009-06-01 |
| Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers (NCT00914641) | Pfizer | 2009-06-01 |
| Effect of a Test Meal on Satiation Hormones in Obese and Normal Weight Adolescents (NCT02020395) | University Hospital, Basel, Switzerland | 2009-06-01 |
| Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers (NCT00912431) | Abbott | 2009-06-01 |
| Class 3 Biowaivers (NCT01010698) | University of Maryland, Baltimore | 2009-06-01 |
| Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD (NCT00524784) | Hadassah Medical Organization | 2009-06-01 |
| Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart) (NCT00914121) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-06-01 |
| LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis (NCT00930813) | C. R. Bard | 2009-06-01 |
| A Drug Interaction Study of SLM0807 and HKB0701 in Healthy Subjects (NCT01039896) | HK inno.N Corporation | 2009-06-01 |
| Effect of Mitomycin C on Urethral Stricture Recurrence After Internal Urethrotomy (NCT00918528) | Hillel Yaffe Medical Center | 2009-06-01 |
| The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers (NCT00925704) | Shire | 2009-06-01 |
| Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia (NCT00933985) | National Cancer Institute (NCI) | 2009-06-01 |
| Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells (NCT01050764) | Everett Meyer | 2009-06-01 |
| A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus (NCT00961909) | Hoffmann-La Roche | 2009-06-01 |
| A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of Digoxin in Healthy Volunteers. (NCT01714206) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-06-01 |
| AZD2066 Cocktail Study (NCT00930306) | AstraZeneca | 2009-06-01 |
| Comparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults (NCT00921947) | VaxInnate Corporation | 2009-06-01 |
| Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis (NCT00937027) | Syntrix Biosystems, Inc. | 2009-06-01 |
| Study to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults (NCT00921206) | VaxInnate Corporation | 2009-06-01 |
| Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure (NCT01092325) | Bristol-Myers Squibb | 2009-06-01 |
| Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma (NCT00920855) | Cephalon | 2009-06-01 |
| Food Effect Study Of AG-013736 In Healthy Volunteers (NCT00918632) | Pfizer | 2009-06-01 |
| Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer (NCT00927147) | Boneca Corporation | 2009-06-01 |
| Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme (NCT00984438) | University of Cincinnati | 2009-06-01 |
| A Study to Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy Volunteers (NCT01149694) | PurGenesis Technologies Inc. | 2009-06-01 |
| Novel Peptide Vaccination for Patients With Advanced Prostate Cancer (NCT01225471) | Iwate Medical University | 2009-06-01 |
| Study to Evaluate Different Extended Release (ER)-Formulations and Multiple Ascending Dosing of AZD3241 (NCT00914303) | AstraZeneca | 2009-06-01 |
| Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib (NCT00890110) | Hadassah Medical Organization | 2009-06-01 |
| Study of [3H] BMS747158 in Healthy Male Subjects (NCT00930631) | Lantheus Medical Imaging | 2009-06-01 |
| A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors (NCT02525536) | Takeda | 2009-06-01 |
| Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (NCT00919958) | Pluristem Ltd. | 2009-06-01 |
| Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer (NCT00928174) | Queen's Medical Center | 2009-06-01 |